 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
Endocare Raises $7 Million In A Private Placement Of Common Stock To Frazier Healthcare Ventures - May 29th, 2007
Endocare To Present At The Friedman, Billings, Ramsey 2007 Growth Conference - May 24th, 2007
First Randomized Head-To-Head Study Shows Cryoablation At Least As Effective As External Beam Radiation For Treating Localized Prostate Cancer - May 22nd, 2007
Endocare Reports 2007 First Quarter Financial Results - May 3rd, 2007
Endocare Sets Date for 2007 First Quarter Results Release and Conference Call - April 24th, 2007
New Study Published in Journal Urology Demonstrates Rapid, High Rate of Return to Sexual Function After Cryoablation - March 15th, 2007
Endocare Reports 2006 Fourth Quarter and Twelve-Month Financial Results - March 9th, 2007
Endocare Sets Date For 2006 Fourth Quarter And Year-End Results Release And Conference Call - February 28th, 2007
UK Health Organization Adds Kidney Cryoablation To Treatment Choices For Patients Throughout England, Scotland, Wales, Northern Ireland - February 7th, 2007
New JAMA Study Confirms Treating Prostate Cancer Preferable to 'Watchful Waiting' - December 22nd, 2006
New Patient Database Enables Presentation Of Safety, Efficacy Data For Cryoablation - December 18th, 2006
18 Cryoablation Studies Presented At National Radiological Society Meeting - November 28th, 2006
Endocare Reports 2006 Third Quarter And Nine Month Results - November 8th, 2006
Endocare Sets Date For 2006 Third Quarter And Nine-Month Results Release And Conference Call - November 1st, 2006
Endocare Enters Into $16 Million Common Stock Purchase Agreement With Fusion Capital - October 30th, 2006
Endocare Named One Of Orange County's Fastest Growing Technology Companies In Deloitte's Technology Fast 50 Program - October 5th, 2006
Published Study Shows Focal Cryoablation Effective In Destroying Prostate Cancer, Preserving Potency, Continence - September 28th, 2006
Endocare Announces Organizational Changes, William J. Nydam Resigns as President & COO - September 25th, 2006
Endocare Receives FDA 510K Clearance To Market New Nitrogen-Based Cryoablation System For Destroying Tissue And Cancerous Tumors - September 12th, 2006
Endocare Reports 2006 Second Quarter And Six Months Results - August 8th, 2006
Endocare To Present At The 2006 Southern California Investor Conference - August 4th, 2006
Endocare Sets Date For 2006 Second Quarter And Six-Month Results And Conference Call - August 2nd, 2006
Cryoablation Studies Published in July Supplement To Journal Urology Demonstrates Effectiveness of Treatment For Kidney Cancer - July 26th, 2006
Endocare Announces Settlements With Securities and Exchange Commission and Department of Justice - July 19th, 2006
26 Cryoablation Studies Presented At National Urology Meeting - May 24th, 2006
First Variable Cryoablation Probe Introduced At National Urology Conference - May 18th, 2006
Endocare Reports 2006 First Quarter Results - May 4th, 2006
Endocare Sets Date For 2006 First Quarter Results Release And Conference Call - April 28th, 2006
Three Cryoablation Studies Presented At Society of Interventional Radiology Annual Meeting - March 31st, 2006
Endocare Reports 2005 Fourth Quarter And Year-End Results - March 7th, 2006
ENDOCARE SETS DATE FOR 2005 FOURTH QUARTER AND YEAR-END RESULTS RELEASE AND CONFERENCE CALL - February 28th, 2006
Endocare Closes Sale of Timm Medical Unit for $9.5 Million - February 13th, 2006
Endocare Agrees to Sell Timm Medical Unit for $9.5 Million - January 13th, 2006
Endocare Announces Plan to Deploy Next Generation Cryoablation Technology for New Applications - November 17th, 2005
Endocare Reports 2005 Third Quarter and Nine Months Results - November 8th, 2005
Endocare Secures Line of Credit From Silicon Valley Bank - November 4th, 2005
Endocare Sets Date For 2005 Third Quarter And Nine-Month Results Release and Conference Call - November 2nd, 2005
Endocare To Present at the CE Unterberg, Towbin Life Science Conference - October 18th, 2005
SEC Declares Endocare S-2 Registration Statement Effective - September 29th, 2005
ENDOCARE HOLDS SPECIAL STOCKHOLDERS' MEETING - August 31st, 2005
ENDOCARE REPORTS 2005 SECOND QUARTER AND SIX MONTHS RESULTS - August 9th, 2005
ENDOCARE SETS DATE FOR 2005 SECOND QUARTER AND SIX-MONTH RESULTS RELEASE AND CONFERENCE CALL - August 2nd, 2005
ENDOCARE ANNOUNCES STRATEGY TO ACHIEVE NATIONAL STOCK MARKET OR EXCHANGE LISTING - July 8th, 2005
ENDOCARE TO PRESENT AT THE CE UNTERBERG, TOWBIN - June 28th, 2005
ENDOCARE HOLDS ANNUAL STOCKHOLDERS MEETING - June 23rd, 2005
ENDOCARE REACHES PRELIMINARY SETTLEMENT WITH SEC REGIONAL STAFF - June 22nd, 2005
FIFTEEN CRYOABLATION STUDIES PRESENTED BY PHYSICIANS AT NATIONAL UROLOGY MEETING - May 31st, 2005
ENDOCARE LAUNCHES EIGHT NEW PRODUCTS AND TECHNOLOGIES AT NATIONAL UROLOGY MEETING - May 23rd, 2005
ENDOCARE REPORTS FIRST QUARTER 2005 RESULTS - May 10th, 2005
ENDOCARE REPORTS COMPLIANCE WITH SECTION 404 OF SARBANES-OXLEY ACT - May 3rd, 2005
ENDOCARE SETS DATE FOR 2005 FIRST QUARTER RESULTS RELEASE AND CONFERENCE CALL - April 27th, 2005
NEW DATA SHOWS CRYOSURGERY EFFECTIVE AS PRIMARY TREATMENT FOR HIGH-RISK PROSTATE CANCER PATIENTS - April 18th, 2005
ENDOCARE CLINICAL STUDIES SELECTED AS FEATURED PRESENTATIONS AT SOCIETY OF INTERVENTIONAL RADIOLOGY ANNUAL MEETING - April 4th, 2005
ENDOCARE SETS ANNUAL STOCKHOLDER MEETING DATE - March 21st, 2005
ENDOCARE REPORTS YEAR-END 2004 RESULTS - March 15th, 2005
© 2003-2004 Endocare, Inc. All rights reserved.